Mediolanum International Funds Ltd Boosts Holdings in Healthpeak Properties, Inc. $DOC

Mediolanum International Funds Ltd increased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 199.7% in the first quarter, Holdings Channel.com reports. The firm owned 395,624 shares of the real estate investment trust’s stock after acquiring an additional 263,628 shares during the period. Mediolanum International Funds Ltd’s holdings in Healthpeak Properties were worth $6,548,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in DOC. Integrated Wealth Concepts LLC lifted its stake in Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after purchasing an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Healthpeak Properties by 110.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP increased its holdings in shares of Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after buying an additional 17,279 shares during the period. Brown Advisory Inc. increased its holdings in shares of Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after buying an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Healthpeak Properties in the 2nd quarter valued at about $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

DOC stock opened at $22.27 on Tuesday. The stock has a market capitalization of $15.36 billion, a price-to-earnings ratio of 69.61, a PEG ratio of 3.50 and a beta of 1.02. The firm’s 50-day moving average price is $20.52 and its two-hundred day moving average price is $18.30. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.72.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.5%. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on DOC shares. Mizuho increased their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, July 6th. Weiss Ratings raised Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Citigroup boosted their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Robert W. Baird increased their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Finally, JPMorgan Chase & Co. increased their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Four analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $20.62.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.